Chu IS - Search Results

1

Transcriptomic Analysis of Papillary Thyroid Cancer: A Focus on Immune-Subtyping, Oncogenic Fusion, and Recurrence.

Park SJ, Kang YE, Kim JH, Park JL, Kim SK, Baek SW, Chu IS, Yi S, Lee SE, Park YJ, Chung EJ, Kim JM, Ko HM, Kim JR, Jung SN, Won HR, Chang JW, Koo BS, Kim SY. Park SJ, et al. Among authors: chu is. Clin Exp Otorhinolaryngol. 2022 May;15(2):183-193. doi: 10.21053/ceo.2021.02215. Epub 2022 Mar 4. Clin Exp Otorhinolaryngol. 2022. PMID: 35255661 Free PMC article.

2

ADGO: analysis of differentially expressed gene sets using composite GO annotation.

Nam D, Kim SB, Kim SK, Yang S, Kim SY, Chu IS. Nam D, et al. Among authors: chu is. Bioinformatics. 2006 Sep 15;22(18):2249-53. doi: 10.1093/bioinformatics/btl378. Epub 2006 Jul 12. Bioinformatics. 2006. PMID: 16837524

3

GAzer: gene set analyzer.

Kim SB, Yang S, Kim SK, Kim SC, Woo HG, Volsky DJ, Kim SY, Chu IS. Kim SB, et al. Among authors: chu is. Bioinformatics. 2007 Jul 1;23(13):1697-9. doi: 10.1093/bioinformatics/btm144. Epub 2007 Apr 27. Bioinformatics. 2007. PMID: 17468122

4

Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer.

Kim SK, Roh YG, Park K, Kang TH, Kim WJ, Lee JS, Leem SH, Chu IS. Kim SK, et al. Among authors: chu is. Clin Cancer Res. 2014 Jun 15;20(12):3233-43. doi: 10.1158/1078-0432.CCR-13-2761. Epub 2014 Apr 8. Clin Cancer Res. 2014. PMID: 24714775

5

Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer.

Lee SR, Roh YG, Kim SK, Lee JS, Seol SY, Lee HH, Kim WT, Kim WJ, Heo J, Cha HJ, Kang TH, Chung JW, Chu IS, Leem SH. Lee SR, et al. Among authors: chu is. Clin Cancer Res. 2015 Dec 1;21(23):5391-403. doi: 10.1158/1078-0432.CCR-14-2680. Epub 2015 Aug 12. Clin Cancer Res. 2015. PMID: 26268246

6

A Database of Gene Expression Profiles of Korean Cancer Genome.

Kim SK, Chu IS. Kim SK, et al. Among authors: chu is. Genomics Inform. 2015 Sep;13(3):86-9. doi: 10.5808/GI.2015.13.3.86. Epub 2015 Sep 30. Genomics Inform. 2015. PMID: 26523133 Free PMC article.

7

Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer.

Song BN, Kim SK, Chu IS. Song BN, et al. Among authors: chu is. Exp Mol Med. 2017 Jan 13;49(1):e282. doi: 10.1038/emm.2016.120. Exp Mol Med. 2017. PMID: 28082741 Free PMC article.

8

Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype.

Oh SC, Sohn BH, Cheong JH, Kim SB, Lee JE, Park KC, Lee SH, Park JL, Park YY, Lee HS, Jang HJ, Park ES, Kim SC, Heo J, Chu IS, Jang YJ, Mok YJ, Jung W, Kim BH, Kim A, Cho JY, Lim JY, Hayashi Y, Song S, Elimova E, Estralla JS, Lee JH, Bhutani MS, Lu Y, Liu W, Lee J, Kang WK, Kim S, Noh SH, Mills GB, Kim SY, Ajani JA, Lee JS. Oh SC, et al. Among authors: chu is. Nat Commun. 2018 May 3;9(1):1777. doi: 10.1038/s41467-018-04179-8. Nat Commun. 2018. PMID: 29725014 Free PMC article.

9

Identification of an immunotherapy-responsive molecular subtype of bladder cancer.

Song BN, Kim SK, Mun JY, Choi YD, Leem SH, Chu IS. Song BN, et al. Among authors: chu is. EBioMedicine. 2019 Dec;50:238-245. doi: 10.1016/j.ebiom.2019.10.058. Epub 2019 Nov 15. EBioMedicine. 2019. PMID: 31735557 Free PMC article.

10

Genomic Signature of the Standardized Uptake Value in ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer.

Kim SK, Ahn SG, Mun JY, Jeong MS, Bae SJ, Lee JS, Jeong J, Leem SH, Chu IS. Kim SK, et al. Among authors: chu is. Cancers (Basel). 2020 Feb 20;12(2):497. doi: 10.3390/cancers12020497. Cancers (Basel). 2020. PMID: 32093417 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page